TABLE 1.
Main dysregulated long non-coding RNAs in Alzheimer’s disease.
LncRNA | Target mRNA | AD-related process | Biological function | References |
BACE1-AS | BACE1 | Aβ deposition | Upregulating BACE1 mRNA stability | Faghihi et al., 2008; Shah et al., 2012; Cortini et al., 2019 |
XIST | BACE1 | Aβ deposition | Upregulating BACE1 mRNA stability | Zhu et al., 2018; Yue et al., 2019 |
51A | SORL1 | Aβ deposition | Downregulating SORL1 variant A | Ciarlo et al., 2013 |
Linc00507 | MAPT/TTBK1 | Tau hyperphosp horylation | Regulating the expression of MAPT and TTBK1 | Yan et al., 2020 |
NEAT1 | FZD3 | Tau hyperphosp horylation | Impairing the FZD3/GSK3β/p-tau signaling pathway | Zhao et al., 2020 |
MALAT1 | IL-10/SOC1 | Neuroin flammation | Regulating the expression of IL-10 and SOC1 | Masoumi et al., 2019; Ma et al., 2019 |
EBF3-AS | EBF3 | Neuronal apoptosis | Promoting neuronal apoptosis in AD | Magistri et al., 2015; Gu et al., 2018 |
SNHG1 | KRENEN1 | Neuronal apoptosis | Target miR-137 to inhibit KREMEN1 | Causeret et al., 2016; Wang et al., 2019 |